Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Toxicological effect of engineered nanomaterials on the liver.

Kermanizadeh A, Gaiser BK, Johnston H, Brown DM, Stone V.

Br J Pharmacol. 2014 Sep;171(17):3980-7. doi: 10.1111/bph.12421. Review.

2.

Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review.

Kermanizadeh A, Balharry D, Wallin H, Loft S, Møller P.

Crit Rev Toxicol. 2015;45(10):837-72. doi: 10.3109/10408444.2015.1058747. Review.

PMID:
26140391
3.

Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model.

Kermanizadeh A, Løhr M, Roursgaard M, Messner S, Gunness P, Kelm JM, Møller P, Stone V, Loft S.

Part Fibre Toxicol. 2014 Oct 20;11:56. doi: 10.1186/s12989-014-0056-2.

4.

Metabolism of nanomaterials in vivo: blood circulation and organ clearance.

Wang B, He X, Zhang Z, Zhao Y, Feng W.

Acc Chem Res. 2013 Mar 19;46(3):761-9. doi: 10.1021/ar2003336.

PMID:
23964655
5.

Effects of manufactured nanomaterials on fishes: a target organ and body systems physiology approach.

Handy RD, Al-Bairuty G, Al-Jubory A, Ramsden CS, Boyle D, Shaw BJ, Henry TB.

J Fish Biol. 2011 Oct;79(4):821-53. doi: 10.1111/j.1095-8649.2011.03080.x. Review.

PMID:
21967577
6.

Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.

Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V.

J Control Release. 2012 Dec 28;164(3):307-13. doi: 10.1016/j.jconrel.2012.08.018. Review.

PMID:
22940205
7.

An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity.

Kermanizadeh A, Vranic S, Boland S, Moreau K, Baeza-Squiban A, Gaiser BK, Andrzejczuk LA, Stone V.

BMC Nephrol. 2013 Apr 25;14:96. doi: 10.1186/1471-2369-14-96.

8.

Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward.

Landsiedel R, Ma-Hock L, Haussmann HJ, van Ravenzwaay B, Kayser M, Wiench K.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Jul-Aug;4(4):399-413. doi: 10.1002/wnan.1173. Review.

PMID:
22639437
9.

Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy.

Farcal L, Torres Andón F, Di Cristo L, Rotoli BM, Bussolati O, Bergamaschi E, Mech A, Hartmann NB, Rasmussen K, Riego-Sintes J, Ponti J, Kinsner-Ovaskainen A, Rossi F, Oomen A, Bos P, Chen R, Bai R, Chen C, Rocks L, Fulton N, Ross B, Hutchison G, Tran L, Mues S, Ossig R, Schnekenburger J, Campagnolo L, Vecchione L, Pietroiusti A, Fadeel B.

PLoS One. 2015 May 21;10(5):e0127174. doi: 10.1371/journal.pone.0127174.

10.

Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application.

Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Matsuo K, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Nakagawa S, Mayumi T, Tsunoda S, Tsutsumi Y.

Biomaterials. 2011 Apr;32(11):2713-24. doi: 10.1016/j.biomaterials.2010.12.042.

PMID:
21262533
11.

Ecotoxicity of silver nanomaterials in the aquatic environment: a review of literature and gaps in nano-toxicological research.

Walters CR, Pool EJ, Somerset VS.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2014;49(13):1588-601. doi: 10.1080/10934529.2014.938536. Review.

PMID:
25137546
12.

Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.

Warheit DB, Borm PJ, Hennes C, Lademann J.

Inhal Toxicol. 2007 Jun;19(8):631-43.

PMID:
17510836
13.

[Safety assessment of nanomaterials for development of nano-cosmetics].

Yoshida T, Yoshioka Y, Tsutsumi Y.

Yakugaku Zasshi. 2012;132(11):1231-6. Review. Japanese.

14.

Exploring the cellular and tissue uptake of nanomaterials in a range of biological samples using multimodal nonlinear optical microscopy.

Johnston HJ, Mouras R, Brown DM, Elfick A, Stone V.

Nanotechnology. 2015 Dec 18;26(50):505102. doi: 10.1088/0957-4484/26/50/505102.

PMID:
26584818
15.

[Safety assessment of nanomaterials in reproductive developmental field].

Yamashita K, Yoshioka Y.

Yakugaku Zasshi. 2012;132(3):331-5. Review. Japanese.

16.

The carcinogenic potential of nanomaterials, their release from products and options for regulating them.

Becker H, Herzberg F, Schulte A, Kolossa-Gehring M.

Int J Hyg Environ Health. 2011 Jun;214(3):231-8. doi: 10.1016/j.ijheh.2010.11.004. Review.

PMID:
21168363
17.

Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.

Wang A, Marinakos SM, Badireddy AR, Powers CM, Houck KA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Sep-Oct;5(5):430-48. doi: 10.1002/wnan.1229.

PMID:
23661551
18.

Health impact and safety of engineered nanomaterials.

Teow Y, Asharani PV, Hande MP, Valiyaveettil S.

Chem Commun (Camb). 2011 Jul 7;47(25):7025-38. doi: 10.1039/c0cc05271j. Review.

PMID:
21479319
19.

Nanomaterials in the aquatic environment: A European Union-United States perspective on the status of ecotoxicity testing, research priorities, and challenges ahead.

Selck H, Handy RD, Fernandes TF, Klaine SJ, Petersen EJ.

Environ Toxicol Chem. 2016 May;35(5):1055-67. doi: 10.1002/etc.3385. Review.

PMID:
27089437
20.

Nanotoxicity: a growing need for study in the endocrine system.

Lu X, Liu Y, Kong X, Lobie PE, Chen C, Zhu T.

Small. 2013 May 27;9(9-10):1654-71. doi: 10.1002/smll.201201517. Review.

PMID:
23401134
Items per page

Supplemental Content

Support Center